91
88
Growth Score
44 pts
Heat Score
86 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
317741
Skape Bio develops AI-designed protein-based biologics for GPCR-targeted drug discovery.
About the Company
Skape Bio develops AI-designed protein-based medicines that target G protein-coupled receptors. The company builds de novo designed functional miniproteins, including agonists and antagonists, to modulate GPCR activity. Its platform integrates generative protein design, native receptor biology, and high-throughput in-cell screening to create
GPCR-targeted biologics. Skape Bio focuses on GPCRs and other challenging drug targets that are difficult to address with traditional small-molecule discovery. The company also partners with pharmaceutical organizations to apply its platform to high-value GPCR targets.
